Abstract
Epigenetics provides a mechanism in which the environment can interact with the genotype to produce a variety of phenotypes. These epigenetic modifications have been associated with altered gene expression and silencing of repetitive elements, and these modifications can be inherited mitotically. DNA methylation is the best characterized epigenetic mark and earlier studies have examined DNA methylation profiles in peripheral blood mononuclear cells in disease. However, any disease-related signatures identified would just display differences in the relative abundance of individual cell types as each cell subset generates a unique methylation profile. Therefore is it important to identify cell- or tissue-specific changes in DNA methylation, particularly in autoimmune diseases such as type 1 diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3:253–266
Bernstein BE, Meissner A, Lander ES (2007) The mammalian epigenome. Cell 128:669–681
Rakyan VK, Down TA, Thorne NP et al (2008) An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 18:1518–1529
Beyan H, Down TA, Ramagopalan SV et al (2012) Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans. Genome Res 22:2138–2145
Dang MN, Buzzetti R, Pozzilli P (2013) Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab Res Rev 29:8–18
Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y (2008) Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29(6):697–725
Rakyan VK, Beyan H, Down TA et al (2011) Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 7, e1002300
Lowe R, Gemma C, Beyan H et al (2013) Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies. Epigenetics 8:1–10
Lyons PA, Koukoulaki M, Hatton A, Doggett K, Woffendin HB, Chaudhry AN, Smith KG (2007) Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics 8:64
Rakyan VK, Down TA, Balding DJ et al (2011) Epigenome-wide association studies for common human diseases. Nat Rev Genet 12:529–541
Acknowledgement
This work was supported by JDRF and BLUEPRINT EU-FP7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Dang, M.N., Bradford, C.M., Pozzilli, P., Leslie, R.D. (2015). Methylation Analysis in Distinct Immune Cell Subsets in Type 1 Diabetes. In: Gillespie, K. (eds) Type-1 Diabetes. Methods in Molecular Biology, vol 1433. Humana Press, New York, NY. https://doi.org/10.1007/7651_2015_286
Download citation
DOI: https://doi.org/10.1007/7651_2015_286
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3641-0
Online ISBN: 978-1-4939-3643-4
eBook Packages: Springer Protocols